PL374044A1 - Sposoby wytwarzania związków pośrednich dla mirtazapiny - Google Patents

Sposoby wytwarzania związków pośrednich dla mirtazapiny

Info

Publication number
PL374044A1
PL374044A1 PL02374044A PL37404402A PL374044A1 PL 374044 A1 PL374044 A1 PL 374044A1 PL 02374044 A PL02374044 A PL 02374044A PL 37404402 A PL37404402 A PL 37404402A PL 374044 A1 PL374044 A1 PL 374044A1
Authority
PL
Poland
Prior art keywords
preparation
methods
mirtazapine
intermediates
mirtazapine intermediates
Prior art date
Application number
PL02374044A
Other languages
English (en)
Inventor
Leonid Metzger
Shlomit Wizel
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of PL374044A1 publication Critical patent/PL374044A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL02374044A 2001-03-01 2002-02-14 Sposoby wytwarzania związków pośrednich dla mirtazapiny PL374044A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27269901P 2001-03-01 2001-03-01

Publications (1)

Publication Number Publication Date
PL374044A1 true PL374044A1 (pl) 2005-09-19

Family

ID=23040907

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02374044A PL374044A1 (pl) 2001-03-01 2002-02-14 Sposoby wytwarzania związków pośrednich dla mirtazapiny

Country Status (10)

Country Link
US (1) US6774230B2 (pl)
EP (1) EP1370549A4 (pl)
JP (1) JP2005501808A (pl)
KR (1) KR20030078086A (pl)
CA (1) CA2438446A1 (pl)
IL (1) IL157607A0 (pl)
IS (1) IS6928A (pl)
NO (1) NO20033840D0 (pl)
PL (1) PL374044A1 (pl)
WO (1) WO2002070513A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
WO2016138357A1 (en) 2015-02-27 2016-09-01 Kindred Biosciences, Inc. Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
AU6474200A (en) * 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound

Also Published As

Publication number Publication date
IS6928A (is) 2003-08-27
NO20033840D0 (no) 2003-08-29
IL157607A0 (en) 2004-03-28
JP2005501808A (ja) 2005-01-20
WO2002070513A1 (en) 2002-09-12
US6774230B2 (en) 2004-08-10
EP1370549A4 (en) 2005-03-09
EP1370549A1 (en) 2003-12-17
US20020165238A1 (en) 2002-11-07
KR20030078086A (ko) 2003-10-04
CA2438446A1 (en) 2002-02-14
WO2002070513A9 (en) 2002-11-21

Similar Documents

Publication Publication Date Title
IL200255A (en) Method of preparing o-desmethyl-venlafaxine
IL146389A0 (en) Process for the preparation of dronedarone
HUP0304041A3 (en) Compounds useful as intermediates
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
EP1425279A4 (en) PROCESS FOR THE PREPARATION OF CRYSTALLINE TETRAHYDROBENZOTHIEPINES
IL159183A0 (en) Method for the preparation of escitalopram
IL146598A0 (en) Method for the preparation of aggregates
IL161714A0 (en) Method for the preparation of escitalopram
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
TWI347945B (en) Process for the preparation of thiazolopyrimidines
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
IL157607A0 (en) Methods for the preparation of mirtazapine intermediates
PL371583A1 (pl) Sposób wytwarzania 7 alfa-metylosteroidów
HUP0401921A3 (en) Intermediate compounds for the preparation of mirtazapine and the production methods thereof
IL164788A0 (en) Process for the preparation of 3-isochromanone
PL368905A1 (pl) Sposób otrzymywania beta-jonylidenoacetaldehydu
HK1058795A (en) Methods for the preparation of mirtazapine intermediates
SI1622926T1 (sl) Nov postopek in intermediati za pripravo 17-halogen-19-nor-steroidnih spojin
ZA200509495B (en) Process for the preparation of nicotinaldehydes
SI1385850T1 (en) New process for the preparation of oxabispidines
HUP0300255A3 (en) Process for the preparation of 2-phenyl-4-methyl-1-tosil-piperazine
GB0105878D0 (en) Novel process for the preparation of pyrazoloprimidinones
HU0104370D0 (en) Honeyed schnaps of oerseg
GB0113667D0 (en) Process for the preparation of endo-5-norbornene-2-ol

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)